Aller au contenu principal
Profil bibliographique

Anthony Obrzut

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées
27Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Adipose Tissue and MetabolismDiet and metabolism studiesTraumatic Brain Injury and Neurovascular DisturbancesChronic Lymphocytic Leukemia ResearchInflammatory Myopathies and Dermatomyositis

Les publications récentes

Accès ouvert 2026 dataset OpenAlex

Rcope: Tools to Cope with Endogeneity Problems

Anthony Obrzut, Yi Qian, Hui Xie

Researchers across disciplines often face biased regression model estimates due to endogenous regressors correlated with the error term. Traditional solutions require instrumental variables (IVs), which are often difficult to find and validate. This package provides flexible, alternative IV-free methods using copulas, as …

0 citations
Accès ouvert 2025 article OpenAlex

Promoting mental well-being among secondary school students in Vietnam using the Y-MIND app: A protocol for a hybrid type 2, sequence pre-post, quasi-experimental study

Jill Murphy, Vu Cong Nguyen, Linh Dang, Hui Wen Xie et autres

Youth mental health is recognized as an urgent priority worldwide. Life skills education and self-management skills delivered at the population level are evidence-based approaches to promote mental well-being and resilience among youth and digital technologies are identified as promising approaches for delivering …

ca, vn, au (code pays fourni par la source)

1 citation PLoS ONE
Accès ouvert 2025 conference-abstract OpenAlex

ABS0847 RETROSPECTIVE SINGLE-CENTRE ANALYSIS OF SURVIVAL AND SAFETY SIGNALS IN AUTOIMMUNE RHEUMATIC DISEASE PATIENTS UNDERGOING LUNG TRANSPLANTATION

Faye A. H. Cooles, Anthony Obrzut, Na Lu, R. Levy et autres

Background: Lung transplant is increasingly offered for severe cardiopulmonary disease in autoimmune rheumatic diseases (ARDs). Patients frequently have extrapulmonary manifestations requiring immunosuppression, but how this affects clinical trajectory post-transplant is unclear. Objectives: Our study objectives were to compare complications post-transplant in people …

ca, gb (code pays fourni par la source)

0 citations Annals of the Rheumatic Diseases
Accès ouvert 2025 conference-abstract OpenAlex

OP0182 BASELINE IMMUNOSUPPRESSION AND CANCER SURVIVAL IN PATIENTS WITH PRE-EXISTING RHEUMATIC DISEASE TREATED WITH IMMUNE CHECKPOINT INHIBITORS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO)

Michael A. Beckett, Carrie Ye, Marie Hudson, Janet Roberts et autres

Background: Immune checkpoint inhibitors (ICI) have revolutionized cancer outcomes, but their optimal use in patients with pre-existing rheumatic disease (PRD) remains largely unknown. There is controversial data on optimal management of baseline immunosuppression (IS) including steroids and disease-modifying antirheumatic drugs (DMARDs), use …

ca (code pays fourni par la source)

0 citations Annals of the Rheumatic Diseases
Accès ouvert 2024 article OpenAlex

Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)

Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, Janet Roberts et autres

Objective Immune checkpoint inhibitors (ICIs) have revolutionized cancer outcomes but are limited by immune-related adverse events (irAEs), including rheumatic irAEs (Rh-irAEs). Aging is associated with increased inflammation, referred to as "inflammaging." In this study, we explore the effect of age on severity, …

ca (code pays fourni par la source)

1 citation The Journal of Rheumatology
2023 article OpenAlex

Tofacitinib therapy in refractory inflammatory myositis: a retrospective cohort study of 41 patients

Madelaine Beckett, Julia Tan, Evelyne Bonnardeaux, Jan Peter Dutz et autres

OBJECTIVES: To evaluate the efficacy and safety of tofacitinib in treatment-refractory inflammatory myositis in a real-world clinical setting. METHODS: All patients with refractory inflammatory myositis treated with tofacitinib from a single urban centre in Vancouver, British Columbia, Canada, were included from June …

ca (code pays fourni par la source)

19 citations Lara D. Veeken

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.